Cargando…

Emerging role of cytoreductive prostatectomy in patients with metastatic disease

Traditionally, systemic androgen deprivation therapy (ADT) has been the primary treatment modality in metastatic prostate cancer (mPCa) while treatment of the primary tumor has been reserved for patients with clinically localized disease. Emerging data suggests that treating the primary tumor in pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jaber, Yasmeen, Reichard, Chad A., Chapin, Brian F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6178312/ https://www.ncbi.nlm.nih.gov/pubmed/30363448 http://dx.doi.org/10.21037/tau.2018.06.06

Ejemplares similares

An Updated Systematic and Comprehensive Review of Cytoreductive Prostatectomy for Metastatic Prostate Cancer
por: Yanagisawa, Takafumi, et al.
Publicado: (2023)

Cytoreductive radical prostatectomy after chemohormonal therapy in patients with primary metastatic prostate cancer
por: Babst, Christa, et al.
Publicado: (2022)

AB056. Cytoreductive radical prostatectomy for men with oligo-metastatic prostate cancer
por: Liu, Shengjie, et al.
Publicado: (2017)

Contemporary outcomes following robotic prostatectomy for locally advanced and metastatic prostate cancer
por: McCormick, Barrett Z., et al.
Publicado: (2021)

Results of Phase 1 study on cytoreductive radical prostatectomy in men with newly diagnosed metastatic prostate cancer
por: Yuh, Bertram E., et al.
Publicado: (2019)

The role of cytoreductive radical prostatectomy and lymph node dissection in bone‐metastatic prostate cancer: A population‐based study
por: Zhai, Tingshuai, et al.
Publicado: (2023)

The current role of cytoreductive nephrectomy for metastatic renal cell carcinoma
por: Umbreit, Eric C., et al.
Publicado: (2021)

Cytoreductive prostatectomy: Evidence in support of a new surgical paradigm (Review)
por: FAIENA, IZAK, et al.
Publicado: (2014)

Current Evidence for the Use of HIPEC and Cytoreductive Surgery in Gastric Cancer Metastatic to the Peritoneum
por: Jain, Anish J., et al.
Publicado: (2023)

Risk of complications and urinary incontinence following cytoreductive prostatectomy: a multi-institutional study
por: Kim, Dae Keun, et al.
Publicado: (2018)

The Role of Cytoreductive Radical Prostatectomy in the Treatment of Newly Diagnosed Low-volume Metastatic Prostate Cancer. Results from the Local Treatment of Metastatic Prostate Cancer (LoMP) Registry
por: Lumen, Nicolaas, et al.
Publicado: (2021)

Cytoreductive prostatectomy improves survival outcomes in patients with oligometastases: a systematic meta-analysis
por: Mao, Yifeng, et al.
Publicado: (2022)

Spermaturia after Radical Prostatectomy: Is Surgical Preservation of Fertility Possible?
por: Reichard, Chad, et al.
Publicado: (2013)

The Evolving Landscape of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma
por: Studentova, Hana, et al.
Publicado: (2023)

Cytoreductive robot‐assisted prostatectomy for systemic prostate rhabdomyosarcoma presenting as urinary retention
por: Kirisawa, Takahiro, et al.
Publicado: (2021)

Cytoreductive Nephrectomy and Nephrectomy/Complete Metastasectomy for Metastatic Renal Cancer
por: Russo, Paul, et al.
Publicado: (2007)

Cytoreductive surgery for men with metastatic prostate cancer
por: Katelaris, Nikolas, et al.
Publicado: (2016)

The Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score is a Novel Significant Prognostic Factor for Patients with Metastatic Prostate Cancer Undergoing Cytoreductive Radical Prostatectomy
por: Guo, Yadong, et al.
Publicado: (2019)

The role of cytoreductive nephrectomy and systemic therapy in the management of tumour thrombus in patients with metastatic renal cell carcinoma
por: Mittal, Abhenil, et al.
Publicado: (2023)

Current role for cytoreduction and HIPEC for gastric cancer with peritoneal disease
por: Khan, Hamza, et al.
Publicado: (2022)

Impact of tumor cytoreduction in metastatic prostate cancer
por: Sow, Yaya, et al.
Publicado: (2019)

Cytoreductive radical prostatectomy or radiation therapy for metastases prostate cancer: Evidence from meta-analysis
por: Peng, Zhixiong, et al.
Publicado: (2022)

Cytoreductive Nephrectomy and Metastatic Renal Cell Carcinoma: State of the Art and Future Perspectives
por: Napolitano, Luigi, et al.
Publicado: (2023)

Health-Related Quality of Life following Cytoreductive Radical Prostatectomy in Patients with De-Novo Oligometastatic Prostate Cancer
por: Chaloupka, Michael, et al.
Publicado: (2021)

Is Cytoreductive Nephrectomy Still a Standard of Care in Metastatic Renal Cell Carcinoma?
por: Renner, Alex, et al.
Publicado: (2019)

Genomic analysis and long-term outcomes of a phase 1 clinical trial on cytoreductive radical prostatectomy
por: Kim, Isaac Yi, et al.
Publicado: (2022)

Role of aggressive surgical cytoreduction in advanced ovarian cancer
por: Chang, Suk-Joon, et al.
Publicado: (2015)

Cytoreductive prostatectomy may improve oncological outcomes in patients with oligometastatic prostate cancer: An updated systematic review and meta-analysis
por: Chung, Doo Yong, et al.
Publicado: (2023)

New Paradigms for Cytoreductive Nephrectomy
por: Lichtbroun, Benjamin J., et al.
Publicado: (2022)

Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma: A Review of the Historical Literature and Its Role in the Era of Targeted Molecular Therapy
por: Aslam, Muhammad Z., et al.
Publicado: (2014)

The impact of histology on survival for patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy
por: Carrasco, Alonso, et al.
Publicado: (2014)

The Effect of Cytoreductive Partial Nephrectomy in Elderly Patients with Metastatic Renal Cell Carcinoma
por: Chen, Jiabi, et al.
Publicado: (2020)

The role of cytoreductive nephrectomy in metastatic renal cell carcinoma in the targeted therapy and immunological therapy era: a systematic review and meta-analysis
por: Chen, Bo, et al.
Publicado: (2023)

The role of radical prostatectomy for the treatment of metastatic prostate cancer: a systematic review and meta-analysis
por: Wang, Yi, et al.
Publicado: (2018)

Cytoreductive nephrectomy for metastatic renal cell carcinoma, the ultimate urologic ‘Choosing Wisely’ campaign: a narrative review
por: Tabakin, Alexandra L., et al.
Publicado: (2020)

Oncological Outcome of Combining Cytoreductive Prostatectomy and Metastasis-Directed Radiotherapy in Patients with Prostate Cancer and Bone Oligometastases: A Retrospective Cohort Study
por: Xue, Peng, et al.
Publicado: (2020)

Clinical Significance of Mesenchymal Circulating Tumor Cells in Patients With Oligometastatic Hormone-Sensitive Prostate Cancer Who Underwent Cytoreductive Radical Prostatectomy
por: Yang, Guanjie, et al.
Publicado: (2022)

Surgical cytoreduction of the primary tumor reduces metastatic progression in a mouse model of prostate cancer
por: CIFUENTES, FEDERICO F., et al.
Publicado: (2015)

Predictors of Cytoreductive Nephrectomy for Metastatic Kidney Cancer in SEER and Metropolitan Detroit Databases
por: Vaishampayan, Ulka, et al.
Publicado: (2019)

Impact of Cytoreductive Nephrectomy on Survival in Patients with Metastatic Renal Cell Carcinoma Treated by Targeted Therapy
por: Song, Yan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ocdlj3pjroq5gfh6jngqihptla